https://pipelinereview.com/European-Commission-Approves-Prolia-denosumab-for-Patients-With-Glucocorticoid-Induced-Osteoporosis/
European Commission Approves Prolia® (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis